“We are delighted to welcome Johanna. Her extensive experience in operational leadership and process excellence will be a tremendous asset as we continue to scale and expand our capabilities. Johanna’s strategic insight and collaborative approach align perfectly with our mission to deliver world-class services to our clients,” says Janet Hoogstraate, CEO NorthX Biologics.

Johanna Magnusson

Johanna Magnusson most recently served as Global Operations Director and Site Leader at Cavidi, where she was instrumental in driving strategic transformation and introducing innovative technologies to the diagnostics and pharmaceutical sectors. Prior to that, Johanna held several senior leadership roles at Cytiva (formerly GE Healthcare) in Uppsala, Sweden, where she led major production initiatives and implemented LEAN and Six Sigma methodologies to significantly enhance productivity and operational performance.

Johanna holds a Master of Science in Chemical Engineering from Umeå University, Sweden, and is a certified Six Sigma Black Belt as well as a certified Board Member through Styrelseakademin. With her international experience, she brings a global mindset to her leadership approach.

“I’m excited to join NorthX Biologics at such a dynamic point in its journey. The company’s end-to-end portfolio — from microbial and mammalian recombinant proteins to viral vectors, mRNA, plasmids, cell therapy, and extracellular vesicles — is truly impressive. I look forward to working with the team to help our clients bring transformative therapies to patients around the world,” says Magnusson.